< Back to companies
Gendius

Gendius

Alderley Edge, United Kingdom

Gendius’ Intellin® platform uses artificial intelligence to actively monitor patients’ diabetes management and uses their clinical history to highlight their risk for developing diabetes-related complications, such as cardiovascular disease, kidney disease, amputation, and blindness. Its algorithms analyse users’ health and wellbeing data to provide individually tailored, clinically-validated educational content and guidance to help people with diabetes to manage their condition more effectively.

Only accessible to MedStartr community members. Join now

Company Info

Founded
2013
Website
www.gendius.co.uk/

Categories

AI / MLCardiovascular DiseaseDiabetes

Disease Areas

Technologies

AI/Machine LearningDiabetes ManagementPredictive AnalyticsRemote Monitoring
Only accessible to MedStartr community members. Join now

What do you think of Gendius?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Innovation

Clinical Benefit

Feasibility

Scalability

Only accessible to MedStartr community members. Join now